Creatine Dosage Guide: Protocols, Calculator & Safety
Everything you need to know about Creatine dosing — protocols, safety, and where to buy.
Dosage Calculator
Calculate exact dosing for Creatine.
Dosing Protocols
Foundation protocol for creatine is designed for users new to creatine supplementation who want to integrate the compound into a basic longevity or fitness regimen with minimal complexity and cost. This protocol captures the full evidence-based benefit of creatine while remaining accessible to a broad user base.
Foundation compound choice: Creatine monohydrate is the gold standard form, with the strongest evidence base and lowest cost. Branded Creapure creatine monohydrate offers additional purity assurance but is not necessary — standard monohydrate from reputable manufacturers with third-party testing provides equivalent benefit. Avoid more expensive alternative forms (creatine HCl, creatine ethyl ester, kre-alkalyn, etc.) that lack superior evidence.
Foundation dose: 3-5 grams of creatine monohydrate daily, taken at any consistent time with food and water. No loading phase required. Muscle saturation achieved over approximately 3-4 weeks. This approach avoids gastrointestinal discomfort associated with loading and reaches the same endpoint as loading protocols.
Foundation timing: Any consistent daily time. Morning is convenient for most users; post-workout is theoretically optimal but practically similar. The key is consistency rather than precise timing. Taking creatine with a meal (breakfast, lunch, or dinner) ensures adequate fluid intake and insulin context.
Foundation duration: Continuous daily supplementation without cycling. Creatine does not require cycling and long-term use maintains full benefit without tolerance issues. For most users, creatine becomes a permanent element of their supplement regimen.
Foundation monitoring: Minimal monitoring required. Users may notice modest weight gain (1-3 kg) within first 2 weeks representing muscle water content increase — this is expected and indicates the compound is working. Strength and performance improvements emerge gradually over 4-12 weeks with consistent training. Inform physicians about creatine supplementation before routine lab testing to allow proper serum creatinine interpretation.
Foundation outcome expectations: Modest but reliable improvements in training capacity, strength gains, lean mass development, and potentially cognitive performance. Users should calibrate expectations: creatine is not a pharmaceutical-grade intervention but rather a reliable, well-validated supplement that provides meaningful benefits across sustained use. Users without resistance training will see minimal ergogenic benefit — the compound is designed to enhance training response, not replace training.
Foundation cost: Among the most cost-effective evidence-based supplements available, typically $10-20 USD per month for standard monohydrate. The cost-to-benefit ratio is exceptional compared to most nootropics or longevity compounds.
This foundation protocol captures the full evidence-based benefit of creatine with minimal complexity and is appropriate as a permanent element of a longevity supplement regimen.
Intermediate protocol for creatine integrates the compound with complementary interventions and optimizes protocol elements for users pursuing more sophisticated longevity or performance goals. This level assumes the user has established tolerability on foundation protocol and wants enhanced integration.
Intermediate loading strategy: Optional loading phase of 20-25 g creatine monohydrate per day (divided into 4-5 doses of 5 g each) for 5-7 days, followed by 3-5 g per day maintenance indefinitely. Loading achieves muscle saturation in approximately one week rather than 3-4 weeks, providing faster onset of performance benefits. Loading is optional — users comfortable with gradual benefit can skip it.
Intermediate dose optimization: 5 g per day standard maintenance dose for most users. Larger users (>200 lb / 90 kg) may benefit from 7-10 g per day to account for larger muscle mass requiring saturation. Smaller users (<140 lb / 65 kg) may do well on 3 g per day.
Intermediate timing optimization: Post-workout administration with carbohydrate and protein-containing meal may slightly enhance muscle uptake via insulin-mediated transport upregulation. Rest-day timing can match a regular meal. This precision timing is not necessary but may provide marginal benefit for optimization-focused users.
Intermediate stack integration: Foundation creatine combined with:
- Quality protein (1.6-2.2 g/kg body weight daily)
- /compound/omega-3-fatty-acids (2-3 g EPA+DHA daily)
- /compound/vitamin-d (2000-5000 IU daily based on blood levels)
- Magnesium (300-400 mg daily, glycinate or threonate form)
- Beta-alanine (3-5 g daily) for users doing interval training
- Consistent resistance training (3-5 sessions weekly)
- Adequate sleep (7-9 hours nightly)
- Balanced whole-food diet
This intermediate stack represents a comprehensive musculoskeletal and metabolic longevity foundation with creatine as an anchor compound.
Intermediate monitoring: Quarterly body composition tracking (lean mass, strength metrics). Serum creatinine interpretation with physician aware of supplementation context. Annual comprehensive metabolic panel including kidney function. Training log review for performance trajectory.
Intermediate outcome expectations: Steady gains in strength and lean mass over 6-12 months of consistent training. Cognitive benefits may emerge particularly under demanding conditions (work stress, sleep deprivation, travel). Energy, mood, and overall resilience improvements reported by many users integrating creatine with comprehensive stack.
Intermediate adjustments: If gastrointestinal discomfort during loading, divide doses smaller (2.5 g × 8 daily) or skip loading entirely. If cognitive effects desired as primary goal, consider 6-8 week timeline for brain saturation rather than 3-4 week muscle saturation window. If training progress plateaus despite creatine, evaluate training program quality, protein intake, and recovery before adjusting creatine protocol.
This intermediate protocol represents the mainstream committed longevity approach for users pursuing sustained musculoskeletal and cognitive optimization through evidence-based interventions.
Advanced protocol for creatine integrates the compound into a comprehensive longevity stack that includes peptide interventions, potentially prescription medications under medical supervision, advanced monitoring, and sophisticated protocol optimization. This level is appropriate for users with extensive longevity practice experience, access to specialist physicians, and willingness to commit substantial resources to multi-pillar optimization.
Advanced compound selection: Creatine monohydrate remains the gold standard even at advanced level — no evidence supports more expensive alternative forms. Users may still prefer Creapure branded monohydrate for purity assurance. The emphasis at advanced level is not on creatine form complexity but on integration with comprehensive stack.
Advanced dose and timing: 5-10 g per day maintenance depending on body size and goals. Twice-daily dosing (2.5-5 g morning and post-workout) may optimize timing effects for users doing intense training. Post-workout administration with carbohydrate-protein nutrition to leverage insulin-mediated uptake enhancement. Loading optional but reasonable for users initiating advanced protocols.
Advanced comprehensive stack integration:
- Creatine 5-10 g daily
- /compound/urolithin-a 500-1000 mg daily (mitophagy support)
- /compound/nmn or /compound/nr 250-500 mg daily (NAD+ precursor)
- /compound/coq10 100-200 mg daily (electron transport support)
- /compound/ss-31 or /compound/mots-c peptide (advanced mitochondrial support, physician-supervised)
- Periodic senolytic cycles: /compound/fisetin 20 mg/kg × 2 days monthly, or /compound/dasatinib + /compound/quercetin combinations quarterly
- /compound/rapamycin 5-8 mg weekly (physician-supervised mTOR modulation)
- Quality protein 2.0-2.5 g/kg body weight daily
- /compound/omega-3-fatty-acids 3-4 g EPA+DHA daily
- /compound/vitamin-d optimized to 50-70 ng/mL serum 25(OH)D
- Advanced training protocols including resistance training 4-5x weekly, Zone 2 cardiovascular training 2-3x weekly, high-intensity interval training 1-2x weekly, mobility and recovery work
This comprehensive advanced stack addresses cellular energy, mitochondrial function, cellular senescence, protein synthesis, and training adaptation across multiple mechanisms.
Advanced monitoring protocols:
- Quarterly comprehensive metabolic panels including detailed kidney function
- Quarterly DXA body composition scans
- Bi-annual VO2max testing and performance benchmarking
- Annual comprehensive longevity panels including biological age markers
- Regular physician consultation (3-4x yearly) with specialist physician for longevity medicine
- Training performance tracking with sophisticated logging
- Sleep quality monitoring (wearable technology or sleep studies)
Advanced outcome expectations: Users at advanced level pursuing comprehensive longevity protocols typically report: substantial strength and lean mass maintenance through middle and older age; cognitive performance preservation; functional capacity equivalent to individuals 10-15 years younger; biological age markers suggesting slower aging trajectory. Creatine contributes meaningfully to these outcomes alongside the broader stack.
Advanced adjustments: Protocol refinement based on individual response, biomarker trends, and evolving goals. Creatine is rarely the element requiring adjustment — its effects are reliable and dose-response is well-characterized. Adjustments more typically involve training periodization, peptide cycling, senolytic intervention timing, and lifestyle optimization.
Advanced cost considerations: Creatine remains inexpensive even within comprehensive advanced stacks. The marginal cost contribution of creatine to total stack cost is typically under 5%, making it one of the highest cost-effectiveness elements regardless of other investment levels.
Advanced integration with medical care: Users at advanced protocol level should work with longevity-focused physicians familiar with advanced supplementation and medication protocols. Creatine does not typically require special medical attention within this context but should be disclosed and discussed as part of overall protocol review.
This advanced protocol represents comprehensive evidence-based longevity optimization with creatine serving as a foundational and reliable anchor compound across the broader intervention framework.
Commonly Stacked With
Creatine stacks well with most other longevity and performance interventions, with minimal negative interactions and multiple synergistic combinations. Understanding stacking strategies helps users integrate creatine into comprehensive protocols.
Foundational longevity stack positioning: Creatine serves as a foundational element of a comprehensive longevity stack alongside /compound/omega-3-fatty-acids (fish oil), /compound/vitamin-d, magnesium, /compound/vitamin-k2, and quality protein intake. This foundational stack addresses musculoskeletal health, cognitive function, cardiovascular health, and bone health through complementary mechanisms. Creatine specifically contributes to muscle performance, lean mass maintenance, cognitive resilience, and bone health (through enhanced training response). Users new to longevity supplementation should prioritize this foundational stack before exploring more speculative interventions.
Resistance training synergy: Creatine's effects are most pronounced when combined with resistance training, producing greater gains in strength and lean mass than either intervention alone. This synergy operates through multiple mechanisms: creatine expands phosphocreatine stores enabling higher training volume and intensity; greater training stimulus drives more robust adaptation; creatine promotes satellite cell activation and protein synthesis enhancing hypertrophy response. Users not already performing regular resistance training should initiate training before or concurrent with creatine supplementation to capture full benefit.
Protein supplementation: Combining creatine with adequate protein intake (1.6-2.2 g/kg body weight daily) optimizes muscle protein synthesis and supports anabolic adaptation to resistance training. Whey protein around workout timing combined with creatine represents a well-established pairing. The combination is not chemically synergistic but rather addresses different components of muscle growth (substrate provision from protein, energy capacity from creatine).
Beta-alanine pairing: Beta-alanine (the precursor to intramuscular carnosine) complements creatine by addressing a different energy system — carnosine buffers muscle acidosis during moderate-duration high-intensity efforts (30 seconds to 3 minutes), while creatine supports the first 10-15 seconds of maximum-intensity effort. The combination benefits users performing activities that span both energy systems (sprint-repeat sports, CrossFit, interval training). Typical beta-alanine dose is 3-5 g per day, with handwashing-like paresthesia as a common harmless side effect.
Carbohydrate co-ingestion: Insulin upregulates the creatine transporter, which is why creatine is traditionally taken with carbohydrate or a meal. This effect is modest in practical terms — creatine still works without carbohydrate co-ingestion — but the combination may marginally improve uptake and store achievement. For users following low-carbohydrate or ketogenic diets, creatine supplementation still works; the absolute magnitude of benefit may be slightly smaller but remains clinically meaningful.
HMB (beta-hydroxy-beta-methylbutyrate): HMB, a leucine metabolite, has some research support for muscle preservation and hypertrophy enhancement. Combining HMB with creatine may provide additive effects for older adults pursuing sarcopenia prevention. HMB dose is typically 3 g per day. The combination is reasonable but not essential for most users.
Caffeine considerations: As noted in side effects, earlier concerns about caffeine-creatine interaction have been largely resolved — modest caffeine consumption does not meaningfully interfere with creatine benefits. Users can reasonably consume both compounds. For competitive athletes where marginal performance differences matter, separating caffeine and creatine timing may provide minor additional benefit, but this is not necessary for mainstream users.
NAD+ precursors: Creatine pairs conceptually with /compound/nmn, /compound/nr, and other NAD+ precursors as a broader approach to cellular energy support. Creatine addresses the phosphocreatine energy system while NAD+ precursors support mitochondrial function and other NAD-dependent processes. The combination addresses energy metabolism from multiple angles and represents a reasonable element of a longevity stack for users interested in cellular energy optimization.
Mitochondrial support: Pairing creatine with /compound/urolithin-a, /compound/coq10, /compound/pqq, or peptide interventions like /compound/ss-31 and /compound/mots-c creates a comprehensive mitochondrial health stack. Creatine provides cellular energy buffering while other compounds address mitochondrial turnover, structural integrity, and biogenesis. The combinations are well-tolerated and conceptually coherent.
Senolytic integration: Creatine pairs well with periodic senolytic interventions (/compound/fisetin, /compound/dasatinib, /compound/quercetin) as part of a multi-pillared longevity approach. Senolytic cycles address cellular senescence while creatine supports ongoing muscle and cognitive function. No negative interactions have been identified between creatine and senolytic protocols.
Rapamycin/metformin: For users on rapamycin or metformin protocols, creatine remains appropriate. There is no mechanistic or clinical reason to exclude creatine from these more advanced protocols. Indeed, creatine may partially compensate for any exercise performance effects of these pharmaceutical interventions.
Hormone optimization context: For users on testosterone replacement therapy, growth hormone protocols, or other hormone optimization, creatine continues to be appropriate and may enhance the muscle-building and performance effects of hormonal interventions. No special precautions are needed beyond general hormone optimization considerations.
Timing strategies: Creatine timing is relatively flexible since muscle stores are maintained over time rather than requiring acute pre-workout administration. Common timing approaches include: with any meal (simple, reliable); with the largest meal of the day (may optimize insulin-mediated uptake); with post-workout nutrition (theoretical benefits of insulin response and training-induced uptake); consistent daily timing regardless of workout schedule (simplest adherence). Research has not established clear superiority of any specific timing; users should choose based on adherence preferences.
Loading vs. maintenance timing: As discussed in mechanism section, loading (20-25 g/day × 5-7 days) vs. maintenance-only (3-5 g/day from start) represent two valid approaches. Loading achieves saturation faster; maintenance approach avoids any gastrointestinal discomfort. For stacking, the loading phase can be initiated independent of other stack elements or concurrently with other stack initiation — no meaningful interactions affect this decision.
Cycling strategies (generally not needed): Unlike some supplements where cycling off is recommended to prevent tolerance or adverse adaptation, creatine does not require cycling. Long-term daily supplementation maintains muscle saturation and ongoing benefits. Users who wish to discontinue periodically may do so without adverse effects — muscle stores return to baseline over approximately 4-6 weeks without supplementation, but this is not necessary for safety or continued efficacy.
Food source integration: Some users prefer obtaining creatine through dietary sources (red meat, fish) rather than supplementation. This approach is reasonable but requires substantial consumption of animal products (approximately 1 pound of beef per day provides approximately 2 g creatine). For most users, supplementation provides more reliable and cost-effective delivery.
Overall stacking position: Creatine is among the best-integrated compounds for stacking, with minimal negative interactions, multiple synergistic pairings, flexible timing, and compatibility across diverse protocols from foundational longevity stacks to advanced peptide interventions. This broad compatibility reflects creatine's role in fundamental cellular energy metabolism — a process relevant to virtually all tissues and interventions.
Side Effects & Safety
Contraindications
Creatine has a favorable contraindication profile, with few absolute contraindications and limited relative contraindications. Understanding who should avoid or approach creatine cautiously helps users make appropriate individual decisions. Absolute contraindications: Very limited. Users with severe active kidney disease (advanced chronic kidney disease, acute kidney injury) should not supplement without nephrologist consultation. Users with known hypersensitivity reactions to creatine products (rare) should avoid. Users on dialysis should consult specialist physicians before supplementation. Relative contraindications (physician consultation recommended): Several situations warrant physician input before or during creatine supplementation. Pre-existing kidney disease (mild-to-moderate): Users with known kidney disease at any stage should consult physicians before creatine supplementation. While available evidence suggests creatine does not worsen kidney disease in most individuals, the population has not been extensively studied and individual circumstances vary. Physicians can evaluate kidney function, medication regimens, and individual factors to provide appropriate guidance. Kidney stones history: Users with history of kidney stones, particularly uric acid or calcium oxalate stones, should discuss with physicians. Evidence for creatine-stone relationship is limited but caution is reasonable. Adequate hydration during supplementation reduces any theoretical risk. Pregnancy and lactation: Insufficient safety data in pregnancy and breastfeeding populations. Default recommendation is to discontinue creatine during pregnancy and lactation unless specific physician approval based on individual circumstances. Adolescents (under 18): Scientific bodies differ on recommendations. International Society of Sports Nutrition supports use in mature adolescent athletes (typically age 14+). Academy of Nutrition and Dietetics is more conservative. Physician consultation and parental involvement appropriate for decisions in this age group. Active liver disease: Insufficient data in severe liver disease. While creatine metabolism occurs primarily in kidney with liver contributing to synthesis, severe liver dysfunction warrants physician evaluation. Diuretic medications: Users on diuretics should ensure adequate hydration with creatine supplementation. No direct negative interaction but combined hydration management warrants attention. Nephrotoxic medications: Users on nephrotoxic medications (certain antibiotics, NSAIDs at high chronic doses, certain chemotherapy agents) should discuss creatine with physicians. The combination may warrant monitoring of kidney function. Lithium therapy: Lithium and creatine share some renal handling pathways in theory. No strong evidence for clinically significant interaction, but patients on lithium should inform psychiatrists about creatine supplementation. Uncontrolled diabetes: While creatine does not directly affect glucose metabolism, users with uncontrolled diabetes should ensure primary diabetes management is optimized before adding non-essential supplements. Non-contraindications often cited incorrectly: Several commonly-cited contraindications are not supported by evidence. Healthy athletes in hot weather: Not a contraindication despite earlier myths. Creatine does not increase dehydration, heat illness, or cramping risk and may slightly improve heat tolerance through improved cellular hydration. Hypertension (well-controlled): Not a contraindication. Creatine does not meaningfully affect blood pressure. Older adults (healthy): Not a contraindication and in fact represents one of the most beneficial populations for supplementation. Chilibeck 2017 meta-analysis (PMID 28956709) supports use in older adults with kidney function considerations standard. Female users: Not a contraindication despite outdated concerns. Women benefit similarly to men from creatine supplementation for strength, cognition, and bone health. Interactions with common supplements: Creatine has minimal significant interactions with other supplements. Common combinations (protein, multivitamins, fish oil, vitamin D, magnesium) are all compatible. Surgery considerations: Creatine does not typically require discontinuation before surgery. However, standard practice of disclosing all supplements to surgical team applies. For major surgery, physicians may recommend discontinuation 1-2 weeks pre-operatively for conservative reasons. Drug testing considerations: Creatine is not banned by any major sports organizations (NCAA, WADA, professional leagues, military). It is legal for use by competitive athletes. Quality-tested products (Informed Sport, NSF Certified for Sport) provide additional assurance of absence of banned substance contamination. Red flag signs warranting discontinuation: - New unexplained kidney function changes - Severe persistent gastrointestinal symptoms - Any allergic reaction (very rare) - Unexpected severe fatigue or weakness - Any symptom suggesting individual adverse response Consultation triggers: Users should consult physicians if they have: any significant medical history; multiple medications; pre-existing kidney disease; recent kidney function abnormalities; any chronic health conditions; uncertainty about appropriateness of supplementation. Risk-benefit framing: For healthy adults without significant medical conditions, creatine's risk profile is among the most favorable of any nutritional supplement. The cost-benefit analysis strongly favors supplementation for most users. For users with significant medical conditions, physician consultation allows individual evaluation but does not necessarily preclude appropriate use. Self-selection guidance: Healthy adults pursuing fitness or longevity goals can reasonably initiate creatine without physician consultation. Users with any medical concerns should consult physicians. Users with pre-existing kidney disease require physician involvement. Users in pregnancy, breastfeeding, or adolescence warrant physician guidance. Summary contraindication position: Creatine is among the safest nutritional supplements available, with limited absolute contraindications, favorable safety profile across diverse populations, and appropriate caution flags rather than outright restrictions for most relative contraindications. The combination of strong safety profile and strong evidence base makes creatine appropriate for broad mainstream use with ordinary attention to individual circumstances and physician consultation when specific concerns apply.
Additional Notes
Creatine oral dosing is straightforward, with extensive research supporting standard protocols. Dosing guidance below covers practical questions: how much, how often, with or without food, loading vs. no loading, and adjustment based on individual factors.
Summary of standard dosing: 3-5 g creatine monohydrate daily with a meal, any consistent time, continuous use without cycling. This protocol achieves muscle saturation over 3-4 weeks and maintains saturation with ongoing supplementation. For most users, this simple approach captures full evidence-based benefit.
Loading phase (optional): 20-25 g per day divided into 4-5 doses of 5 g each, for 5-7 days. Achieves muscle saturation in approximately one week. After loading, transition to 3-5 g per day maintenance indefinitely. Loading is optional; skipping it delays full effect by 2-3 weeks but achieves the same endpoint with better gastrointestinal tolerability.
Body-size dosing: For body weight adjustment: smaller users (<60 kg / 132 lb) may do well on 3 g per day; average users (60-90 kg / 132-200 lb) standard 3-5 g per day; larger users (>90 kg / 200 lb) may benefit from 5-10 g per day maintenance to account for larger muscle mass requiring saturation.
Timing considerations: Specific timing is less important than consistency. Common timing options: with breakfast (simple, reliable); post-workout (theoretical insulin advantage, practical post-workout habit); with largest meal of day (insulin response leverages uptake); bedtime (not recommended due to fluid intake timing). For adherence, pair creatine with an established daily habit (first coffee, pre-workout, etc.) to ensure consistency.
Food context: Taking creatine with a meal, particularly one containing carbohydrates and protein, may marginally enhance uptake via insulin-mediated upregulation of creatine transporter. In practical terms, this effect is small — creatine works on empty stomach as well. For convenience, any reliable daily meal works.
Formulation selection: Creatine monohydrate remains evidence-based gold standard. Micronized creatine (smaller particle size for improved mixability) is identical chemically and functions equivalently. Creapure is a branded German-manufactured creatine monohydrate with high purity assurance — worth consideration for users preferring premium quality markers but not necessary. Avoid expensive alternative forms (ethyl ester, HCl, buffered, etc.) that lack superior evidence.
Delivery method: Powder mixed with water, juice, or shake is standard and most cost-effective. Capsules available for convenience (typically 10-20 capsules per 5 g dose). Flavored creatine products marketed for taste appeal are acceptable but add cost without efficacy benefit.
Mixing and dissolution: Creatine monohydrate dissolves in water but not instantaneously — some residue may remain. Use warm water for better dissolution; stir thoroughly; consume promptly (prolonged standing in solution can degrade creatine to creatinine). Micronized creatine dissolves more readily than standard monohydrate.
Storage: Powder stored in cool dry location in original container with tight seal. Capsules similarly stored. Creatine is stable for 2-3 years under appropriate storage; check expiration dates on packaging.
Hydration: General adequate hydration (2-3 liters daily for most adults) is recommended with creatine supplementation, as with any supplementation protocol. Creatine does not cause dehydration but appropriate fluid intake supports overall health and may marginally improve creatine transport and cellular uptake.
Maintenance adjustments: Dose can be adjusted based on training status, body size, and individual response. Users feeling full effect at 3 g daily need not increase; users not perceiving benefit at 5 g may experiment with 7-10 g to evaluate. Most users find optimal dose within 3-5 g range.
Discontinuation: If discontinuing creatine, no tapering required. Muscle creatine stores return to baseline over approximately 4-6 weeks. Performance and lean mass gains may partially regress with discontinuation, though training adaptations are maintained longer.
Re-initiation: If resuming creatine after discontinuation, loading or maintenance-only restart both appropriate. No special considerations for re-initiation.
Specific populations:
- Older adults: Same standard dosing, with particular emphasis on combined resistance training for maximum benefit. Chilibeck 2017 meta-analysis (PMID 28956709) supports standard dosing in this population.
- Vegetarians/vegans: Same standard dosing, with potentially more pronounced benefit due to lower baseline stores from dietary absence of creatine.
- Women: Same standard dosing as men, scaled for body size. No special considerations beyond those applicable to men.
- Younger athletes (under 18): Case-by-case physician decision — some bodies support use in mature adolescent athletes; others recommend waiting.
- Endurance athletes: Standard dosing, with recognition that ergogenic benefit is smaller than for strength/power athletes but may aid recovery between high-intensity intervals.
Cost and value: At standard dosing, monthly creatine cost is typically $10-20 USD for quality monohydrate. Cost-per-effect ratio is exceptional relative to most supplements and many medications. Even at advanced dosing (10 g/day), monthly cost rarely exceeds $30.
Protocol simplicity summary: Take 5 g creatine monohydrate with breakfast daily. Maintain indefinitely. Exercise regularly. This minimal protocol captures full evidence-based benefit and is among the simplest effective longevity interventions available.
Frequently Asked Questions
What is the recommended Creatine dosage?
Dosage for Creatine varies by protocol. Consult a qualified healthcare provider.
How often should I take Creatine?
Administration frequency depends on the specific protocol. Consult current research literature.
Does Creatine need to be cycled?
Cycling requirements depend on the protocol. Follow established research guidelines.
What are Creatine side effects?
Creatine has one of the most favorable safety profiles of any nutritional supplement, with extensive human use experience, multiple long-term safety studies, and consensus from scientific bodies affirming safety in healthy populations. Side effects are generally mild, uncommon, and well-managed with minor protocol adjustments. Weight gain (expected and non-problematic): The most consistent effect of creatine supplementation is weight gain of 1-3 kg within the first 1-2 weeks of use, reflecting increased muscle water content (creatine draws water into muscle cells osmotically). This weight gain is expected, physiological rather than adipose, and represents the mechanism by which creatine works rather than a problem. Users should anticipate this weight gain and understand it as a desired effect. In populations where minimal weight gain is a priority (wrestlers, weight-class athletes), creatine timing may need consideration relative to competition. Gastrointestinal discomfort (uncommon, protocol-manageable): Some users experience mild gastrointestinal discomfort (nausea, bloating, stomach cramping, diarrhea) particularly during loading phases with large single doses. These symptoms are typically avoided by: dividing loading doses into 4-5 smaller doses throughout the day (5 g × 5 daily rather than 20 g × 1); skipping the loading phase and using maintenance dosing (3-5 g per day) from the start; taking creatine with meals rather than on empty stomach; using micronized creatine which dissolves better; ensuring adequate hydration. Muscle cramping (not supported by evidence despite common belief): The widely-held belief that creatine causes muscle cramping is not supported by clinical evidence. Multiple studies in athletic populations have found that creatine supplementation does not increase (and may slightly decrease) cramping, dehydration, or heat-related illness compared to placebo. This persistent myth appears to reflect misconception rather than actual physiological effect. Adequate hydration with creatine supplementation is always reasonable and should be standard practice. Kidney function (not affected in healthy individuals): The persistent belief that creatine damages kidneys is thoroughly refuted by clinical evidence. Multiple long-term studies have demonstrated no adverse effects on kidney function (measured by GFR, serum creatinine interpretation adjusted for supplementation, urinary markers) in healthy individuals taking creatine for periods of 5 years or longer. Creatine supplementation does elevate serum creatinine levels above baseline due to increased creatine pool turnover, which can cause confusion in routine lab interpretation — this elevation does not reflect kidney damage but rather altered creatinine dynamics from supplementation. Users should inform their physicians about creatine supplementation before lab testing to allow proper interpretation. Kidney disease (caution warranted): Users with pre-existing kidney disease should consult physicians before creatine supplementation. While creatine does not appear to worsen kidney disease in most analyses, individuals with compromised kidney function warrant physician oversight and potentially different dosing strategies. The International Society of Sports Nutrition position stand recommends physician consultation for users with any kidney disease. Liver function (not affected): Creatine supplementation does not adversely affect liver function in healthy individuals, based on multiple studies tracking liver enzymes (ALT, AST) and other markers during sustained supplementation. Cardiovascular effects (neutral to favorable): Creatine does not appear to adversely affect cardiovascular parameters. Some research suggests potential cardiovascular benefits through improved energy metabolism in heart tissue and reduced homocysteine levels, though these potential benefits are not strong enough to recommend creatine specifically for cardiovascular purposes. Hormonal effects (minimal): Creatine supplementation does not significantly alter testosterone, estrogen, or other major hormonal parameters. Some research has suggested modest elevations in dihydrotestosterone (DHT) levels in certain contexts, leading to speculation about potential effects on hair loss in susceptible individuals — this connection remains debated and is not well-established. For users concerned about hair loss, alternatives or monitoring may be considered, but the overall evidence does not support strong hormonal concerns with creatine supplementation. Skin effects (rare): Isolated reports of skin reactions (acne exacerbation, mild rashes) have appeared in the literature but are not consistent findings. For most users, no skin effects occur. Dehydration risk (not supported): The concern that creatine causes dehydration is not supported by evidence. Some research suggests creatine may actually improve hydration status during exercise due to increased cellular water content. Standard hydration practices with creatine supplementation are recommended but no special precautions are required. Interactions with medications: Creatine has minimal clinically significant drug interactions. The most relevant consideration is for medications that affect kidney function (nephrotoxic drugs including NSAIDs at high doses, certain antibiotics) where the combination may warrant physician consultation. No significant interactions with common supplements have been identified. Interactions with caffeine: Early research suggested caffeine might reduce creatine's ergogenic effects. Subsequent research has been mixed, with many studies finding no interaction. Current consensus is that modest caffeine consumption does not meaningfully interfere with creatine benefits. Users can reasonably consume both compounds. Special populations: - Pregnant and breastfeeding women: Limited safety data in pregnancy and breastfeeding. While no clear evidence of harm exists, default recommendation is to discontinue during pregnancy and lactation unless physician-approved. - Children and adolescents: Creatine supplementation in adolescent athletes is debated. Some scientific bodies support use in well-trained adolescent athletes; others recommend waiting until adulthood. Individual circumstances and medical guidance should govern decisions in this population. - Elderly with multiple comorbidities: For users with multiple chronic conditions, polypharmacy, or cognitive impairment, physician consultation before initiation is prudent. - Vegetarians and vegans: These populations typically benefit most from creatine supplementation (due to lower baseline stores from dietary absence) and have no special safety concerns beyond those applicable to omnivores. Overall safety summary: Creatine is among the safest nutritional supplements available, with decades of use experience, extensive safety research, and minimal side effect profile in healthy individuals. The persistent myths about kidney damage and cramping are not supported by evidence. Users should understand that weight gain is expected and represents the intended effect. Gastrointestinal discomfort during loading is manageable with protocol adjustments. Pre-existing kidney disease warrants physician consultation, but otherwise the compound is appropriate for mainstream use without special medical oversight.
Where can I buy Creatine?
Visit our vendor directory to find trusted sources for Creatine.
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.
